Medical Devices
-
Sterile Devices in Premarket Notification [510(k)] Submissions

Review Template
Sterile Devices in Premarket Notification [510(k)] Submissions
1 Updated 510(k) Sterility Review Guidance K90-1; Final Guidance for Industry and FDA Document Issued on: August 30, 2002
2 Medical Device User Fee and Modernization Act of 2002, Validation Data in Premarket Notification Submissions (510(k)s) for Reprocessed Single Use Devices
Read text description of Sterile Devices in Premarket [510(k)] Submissions Review Template
| 1. Sterilant: | YES | NO |
| a. Sterilization method description (e.g., Steam, EtO, Radiation): |
|
|
| b. Dose, for radiation (e.g., 25 – 40 kGy): |
|
|
| c. Sterilant residuals remaining on the device: For EO, the maximum levels of residuals of EO and ethylene chlorhydrin that remain on the device (note: not to include ethylene glycol residual level because the recognized standard, "ANSI/AAMI/ISO 10993-7:1995 Biological Evaluation of Medical Devices – Part 7: Ethylene Oxide sterilization residuals," does not include measurement of ethylene glycol residuals); |
|
|
| 2. A description of the Validation Method for the sterilization cycle (not data): (Citation of an FDA recognized standard is acceptable (e.g., ANSI/AAMI/ISO 11135)) |
|
|
| 3. Sterility assurance level (SAL): (e.g., 10 -6 for all devices (except 10 -3 for devices that contact intact skin)) |
|
|
| 4. Is it labeled “Pyrogen Free”? |
|
|
| If so, a description of the method: (e.g., LAL (Limulus Amebocyte Lysate test)) |
|
|
| 5. A description of the packaging (not including package integrity test data): |
|
|
-
-








